Hu, Y., Tao, H., Luo, Y., Yang, H., Su, W., Yu, Y., Zhou, J., Han, Q., Chen, P., Wang, H., Dang, Q., Wang, Q., Sun, L., Zhang, Z., Ren, S., Zhao, M., Chen, Q., Ding, Q., Zhang, Y., Xu, C. (2026). SHR-A2102 in combination with adebrelimab as first-line treatment in patients with locally advanced or metastatic squamous or non-squamous non-small cell lung cancer (NSCLC): Results from a phase 1b/2 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8527